Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Adding montelukast as effective as doubling budesonide dose in asthma patients

Sep. 26, 2002

Roflumilast safe and effective in patients with asthma and COPD

Sep. 26, 2002

Safety data for omalizumab reported at the 2002 ERS congress

Sep. 25, 2002

Benefits of tiotropium in COPD become evident upon withdrawal

Sep. 25, 2002

First Rigel compound enters clinical testing for allergic rhinitis

Sep. 25, 2002

Cilomilast proven effective in improving lung function of smoking and nonsmoking COPD patients

Sep. 23, 2002

Theravance describes multibinding H1 antagonists for allergic rhinitis and other uses

Sep. 20, 2002

New PDE4 inhibitors designed by Ono

Sep. 20, 2002

KW-4490 advances to phase II as a potential asthma therapeutic

Sep. 19, 2002

Dual PDE3/PDE4 inhibitor attenuates inflammation and bronchoconstriction in ARDS

Sep. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.